Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

BI-3802 is a degrader of Bcl-6 with a half-maximal degradation concentration (DC50) value of 20 nM in SU-DHL-4 B cell lymphoma cells.1 It binds to Bcl-6 in a cell-free assay and inhibits the interaction of Bcl-6 with nuclear receptor co-repressor 1 (NCOR1) in a reporter assay (IC50s = ≤3 and 43 nM, respectively). BI-3802 induces Bcl-6 polymerization, as well as SIAH1-dependent ubiquitination of Bcl-6, in cell-free assays.2 It induces expression of the Bcl-6 target genes PTPN6 and RAPGEF1 in SU-DHL-4 cells in a concentration- and time-dependent manner.1 BI-3802 enhances decreases in tumor volume and weight induced by the c-Abl, Bcr-Abl, PDGFR, and c-Kit inhibitor imatinib (Item No. 13139) in a GIST-T1 gastrointestinal stromal tumor mouse xenograft model.3
WARNING This product is not for human or veterinary use.
1. Chemically induced degradation of the oncogenic transcription factor BCL6. Cell. Rep. 20(12), 2860-2875 (2017).
2. Small-
3. Targeting BCL6 in gastrointestinal stromal tumor promotes p53-